Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2015

01-05-2015 | Colorectal Cancer

Histologic Categorization of Desmoplastic Reaction: Its Relevance to the Colorectal Cancer Microenvironment and Prognosis

Authors: Hideki Ueno, MD, PhD, Eiji Shinto, MD, PhD, Hideyuki Shimazaki, MD, PhD, Yoshiki Kajiwara, MD, PhD, Takahiro Sueyama, MD, Junji Yamamoto, MD, PhD, Kazuo Hase, MD, PhD

Published in: Annals of Surgical Oncology | Issue 5/2015

Login to get access

Abstract

Background

Although the essential roles of stromata in tumor development have been recognized, the morphologic classification of desmoplastic reaction (DR) in colorectal cancer (CRC) is unclear.

Methods

In this study, DRs were histologically classified into three patterns based on the products of activated fibroblasts (i.e., keloid-like collagen and myxoid stroma). The prognostic impact of DRs was evaluated in two independent cohorts of stages 2 and 3 CRC patients: cohort 1 (880 patients) and cohort 2 (474 patients). The association of DR and the local environment was investigated immunohistochemically.

Results

In cohort 1, mature DR was shown by 413 patients, intermediate DR by 275 patients, and immature DR by 192 patients. Categorization of DR was significantly associated with tumor location, pT and pN stages, tumor differentiation, venous invasion, tumor budding, and Crohn’s-like lymphoid reaction (P ≤ 0.0001–0.008). Immature DR was relevant to the high incidence of recurrence in the liver, lung, lymph nodes, peritoneum, and locoregional areas (P ≤ 0.0001–0.002). The 5-year disease-free survival rate was highest in the mature group (87 %), followed by the intermediate group (72 %) and the immature group (49 % (P < 0.0001). In the multivariate analysis, DR showed an impact on survival outcome independent of conventional prognostic factors, including pT and pN stages. These results were similarly observed in cohort 2. Immature DR was associated with normal MutL homologue 1 (MLH1)/MutS homologue 2 (MSH2) immunoreactivity, a smaller number of infiltrating CD8+ T cells and tumor-associated macrophages, a decreased microvessel count, and positive expression of tenascin-C and fibronectin.

Conclusion

The proposed histologic DR categorization directly reflects tumor behavior in a modulating stromal environment and could provide valuable prognostic information for CRC patients.
Literature
1.
go back to reference Pietras K, Östman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010;316:1324–31.CrossRefPubMed Pietras K, Östman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010;316:1324–31.CrossRefPubMed
2.
go back to reference McAllister SS, Weinberg RA. Tumor–host interactions: a far-reaching relationship. J Clin Oncol. 2010;28:4022–8.CrossRefPubMed McAllister SS, Weinberg RA. Tumor–host interactions: a far-reaching relationship. J Clin Oncol. 2010;28:4022–8.CrossRefPubMed
3.
5.
go back to reference Östman A, Augsten M. Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr Opin Genet Dev. 2009;19:67–73.CrossRefPubMed Östman A, Augsten M. Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr Opin Genet Dev. 2009;19:67–73.CrossRefPubMed
6.
go back to reference Peña C, Céspedes MV, Lindh MB, et al. STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. Cancer Res. 2012;73:1287–87.CrossRefPubMed Peña C, Céspedes MV, Lindh MB, et al. STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. Cancer Res. 2012;73:1287–87.CrossRefPubMed
7.
go back to reference Hewitt RE, Powe DG, Carter GI, Turner DR. Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer. 1993;53:62–9.CrossRefPubMed Hewitt RE, Powe DG, Carter GI, Turner DR. Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer. 1993;53:62–9.CrossRefPubMed
8.
go back to reference Ueno H, Jones A, Jass JR, Talbot IC. Clinicopathological significance of the “keloid-like” collagen and myxoid stroma in advanced rectal cancer. Histopathology. 2002;40:327–34.CrossRefPubMed Ueno H, Jones A, Jass JR, Talbot IC. Clinicopathological significance of the “keloid-like” collagen and myxoid stroma in advanced rectal cancer. Histopathology. 2002;40:327–34.CrossRefPubMed
9.
go back to reference Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut. 2004;53:581–6.CrossRefPubMedCentralPubMed Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut. 2004;53:581–6.CrossRefPubMedCentralPubMed
10.
go back to reference Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40:127–32.CrossRefPubMed Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour “budding” as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40:127–32.CrossRefPubMed
11.
go back to reference Ueno H, Mochizuki H, Hashiguchi Y, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127:385–94.CrossRefPubMed Ueno H, Mochizuki H, Hashiguchi Y, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127:385–94.CrossRefPubMed
12.
go back to reference Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2009;17:1–29.CrossRef Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2009;17:1–29.CrossRef
13.
go back to reference Graham DM, Appelman HD. Crohn’s-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol. 1990;3:332–5.PubMed Graham DM, Appelman HD. Crohn’s-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol. 1990;3:332–5.PubMed
14.
go back to reference Ueno H, Hashiguchi Y, Shimazaki H, et al. Objective criteria for Crohn-like lymphoid reaction in colorectal cancer. Am J Clin Pathol. 2013;139:434–41.CrossRefPubMed Ueno H, Hashiguchi Y, Shimazaki H, et al. Objective criteria for Crohn-like lymphoid reaction in colorectal cancer. Am J Clin Pathol. 2013;139:434–41.CrossRefPubMed
15.
go back to reference Hiraoka K, Miyamoto M, Cho Y, et al. Concurrent infiltration by CD8+T cells and CD4+T cells in a favorable prognostic factor in non–small-cell lung carcinoma. Br J Cancer. 2006;94:275–80.CrossRefPubMedCentralPubMed Hiraoka K, Miyamoto M, Cho Y, et al. Concurrent infiltration by CD8+T cells and CD4+T cells in a favorable prognostic factor in non–small-cell lung carcinoma. Br J Cancer. 2006;94:275–80.CrossRefPubMedCentralPubMed
16.
go back to reference Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8.CrossRefPubMed Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8.CrossRefPubMed
17.
go back to reference Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Salmas M, Malamou-Mitsi V. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma. BJU Int. 2005;95:655–9.CrossRefPubMed Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Salmas M, Malamou-Mitsi V. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma. BJU Int. 2005;95:655–9.CrossRefPubMed
18.
go back to reference Kressner U, Lindmark G, Tomasini-Johansson B, et al. Stromal tenascin distribution as a prognostic marker in colorectal cancer. Br J Cancer. 1997;76:526–30.CrossRefPubMedCentralPubMed Kressner U, Lindmark G, Tomasini-Johansson B, et al. Stromal tenascin distribution as a prognostic marker in colorectal cancer. Br J Cancer. 1997;76:526–30.CrossRefPubMedCentralPubMed
19.
go back to reference McDonald LT, LaRue AC. Hematopoietic stem-cell-derived carcinoma-associated fibroblasts: a novel origin. Int J Clin Exp Pathol. 2012;5:863–73.PubMedCentralPubMed McDonald LT, LaRue AC. Hematopoietic stem-cell-derived carcinoma-associated fibroblasts: a novel origin. Int J Clin Exp Pathol. 2012;5:863–73.PubMedCentralPubMed
21.
go back to reference Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H. Keloids: current concepts of pathogenesis (review). Int J Mol Med. 2009;24:283–93.CrossRefPubMed Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H. Keloids: current concepts of pathogenesis (review). Int J Mol Med. 2009;24:283–93.CrossRefPubMed
22.
go back to reference Desmoulière A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol. 2004;48:509–17.CrossRefPubMed Desmoulière A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol. 2004;48:509–17.CrossRefPubMed
23.
go back to reference Hanamura N, Yoshida T, Matsumoto E, Kawarada Y, Sakakura T. Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells, and epithelial cells in human colon adenomas and carcinomas. Int J Cancer. 1997;73:10–15.CrossRefPubMed Hanamura N, Yoshida T, Matsumoto E, Kawarada Y, Sakakura T. Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells, and epithelial cells in human colon adenomas and carcinomas. Int J Cancer. 1997;73:10–15.CrossRefPubMed
24.
go back to reference Guttery DS, Shaw JA, Lloyd K, Pringle JH, Walker RA. Expression of tenascin-C and its isoforms in the breast. Cancer Metastasis Rev. 2010;29:595–606.CrossRefPubMed Guttery DS, Shaw JA, Lloyd K, Pringle JH, Walker RA. Expression of tenascin-C and its isoforms in the breast. Cancer Metastasis Rev. 2010;29:595–606.CrossRefPubMed
25.
go back to reference Lieubeau B, Heymann MF, Henry F, Barbieux I, Meflah K, Grégoire M. Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer. 1999;81:629–36.CrossRefPubMed Lieubeau B, Heymann MF, Henry F, Barbieux I, Meflah K, Grégoire M. Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer. 1999;81:629–36.CrossRefPubMed
26.
go back to reference Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989;339:58–61.CrossRefPubMed Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989;339:58–61.CrossRefPubMed
29.
go back to reference Wright CL, Stewart ID. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas. Am J Surg Pathol. 2003;27:1393–406.CrossRefPubMed Wright CL, Stewart ID. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas. Am J Surg Pathol. 2003;27:1393–406.CrossRefPubMed
Metadata
Title
Histologic Categorization of Desmoplastic Reaction: Its Relevance to the Colorectal Cancer Microenvironment and Prognosis
Authors
Hideki Ueno, MD, PhD
Eiji Shinto, MD, PhD
Hideyuki Shimazaki, MD, PhD
Yoshiki Kajiwara, MD, PhD
Takahiro Sueyama, MD
Junji Yamamoto, MD, PhD
Kazuo Hase, MD, PhD
Publication date
01-05-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 5/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4149-9

Other articles of this Issue 5/2015

Annals of Surgical Oncology 5/2015 Go to the issue